The impact of clozapine treatment on serum lipids in chronic schizophrenic patients

Clinical Neuropharmacology

Volumn 22, Issue 2, 1999, Pages 98-101

  Spivak, B ^a   Lamschtein, C ^a   Talmon, Y ^a   Guy, N ^a   Mester, R ^a   Feinberg, I ^a   Kotler, M ^a   Weizman, A ^a  

^a NESS ZIONA MENTAL HEALTH CENTER   (Israel)

Author keywords

Cholesterol; Classical antipsychotic agents; Clozapine; Lipids; Schizophrenia; Triglycerides

Indexed keywords

CHOLESTEROL; CLOZAPINE; LIPID; NEUROLEPTIC AGENT; TRIACYLGLYCEROL;

ADULT; AGGRESSION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033303403     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199903000-00006     Document Type: Article

References (21)

1. Cholesterol and mental disorder
2. Serum cholesterol levels in homicidal offenders: A low cholesterol level is connected with a habitually violent tendency under the influence of alcohol
3. Serum cholesterol in antisocial personality
4. Serum cholesterol in aggressive conduct disorder: A preliminary study
5. Serum cholesterol and suicidal tendencies in psychiatric inpatients
6. Low serum cholesterol level and attempted suicide
7. Total cholesterol and suicidality in depression
8. Low serum cholesterol in suicide attempters
9. A self report measure of violence risk
10. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact of risk benefit assessment
11. Serum cholesterol and treatment-resistance in schizophrenia
12. Serotonin function and treatment response to clozapine in schizophrenic patients
13. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital
14. Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients
15. Diminished suicidal and aggressive behavior and high plasma norepinephrine and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine
16. Clozapine for the treatment resistant schizophrenic: A double-blind comparison with chlorpromazine
17. The overt aggression scale for the objective rating of verbal and physical aggression
18. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge
19. Investigating the role of lipids in mood, aggression and schizophrenia
20. Serum cholesterol and aggression in hospitalised male forensic patients
21. Increased serum triglyceride levels in patients treated with clozapine